Pactiv General Employee Benefit Trust’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-379,505
Closed -$90.3M 9
2021
Q2
$90.3M Sell
379,505
-373,785
-50% -$82.9M 6.19% 5
2021
Q1
$150M Hold
753,290
6.77% 3
2020
Q4
$148M Hold
753,290
5.64% 4
2020
Q3
$144M Hold
753,290
6.4% 4
2020
Q2
$118M Buy
753,290
+99,840
+15% +$14.3M 6.01% 3
2020
Q1
$80.2M Buy
653,450
+223,344
+52% +$30.1M 8.58% 4
2019
Q4
$58.5M Buy
430,106
+250,077
+139% +$31.6M 5.34% 10
2019
Q3
$23.1M Buy
+180,029
New +$22.5M 2.22% 17

Other funds holding DHR

Pactiv General Employee Benefit Trust's DHR Position: Q3 2021 in Review

Pactiv General Employee Benefit Trust sold out of Danaher (DHR) in Q3 2021, closing a stake of 379,505 shares — an estimated $90.3M sold.

Pactiv General Employee Benefit Trust first reported a position in DHR in Q3 2019 and held it in 8 quarters. The position peaked at $150M in Q1 2021. 1,894 funds tracked by Wall St. Rank hold DHR as of Q3 2021.

  • Pactiv General Employee Benefit Trust reported no remaining Danaher position as of Q3 2021 after selling out during the quarter.
  • Pactiv General Employee Benefit Trust sold 379,505 Danaher shares in Q3 2021, an estimated $90.3M.
  • Pactiv General Employee Benefit Trust first reported a position in Danaher in Q3 2019 and held it in 8 quarters.
  • Pactiv General Employee Benefit Trust's Danaher position peaked at $150M in Q1 2021.
  • 1,894 funds tracked by Wall St. Rank held Danaher as of Q3 2021.

Based on Pactiv General Employee Benefit Trust's 13F filing for Q3 2021, filed 15 Nov 2021.